{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:24:30Z","timestamp":1779171870391,"version":"3.51.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T00:00:00Z","timestamp":1681689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AG059301"],"award-info":[{"award-number":["P30 AG059301"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP210130"],"award-info":[{"award-number":["RP210130"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s00432-023-04778-z","type":"journal-article","created":{"date-parts":[[2023,4,17]],"date-time":"2023-04-17T08:02:32Z","timestamp":1681718552000},"page":"8255-8265","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Use of weight loss medications in relation with prostate, colorectal and male breast cancers among older men: SEER-Medicare 2007\u20132015"],"prefix":"10.1007","volume":"149","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2321-0372","authenticated-orcid":false,"given":"David S.","family":"Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunkyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstathia","family":"Polychronopoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa E.","family":"Torres-Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Villasante-Tezanos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Baillargeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Canfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Fang","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,17]]},"reference":[{"issue":"10","key":"4778_CR1","doi-asserted-by":"publisher","first-page":"4522","DOI":"10.1210\/jc.2002-020567","volume":"87","author":"N Abate","year":"2002","unstructured":"Abate N, Haffner SM, Garg A, Peshock RM, Grundy SM (2002) Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endocrinol Metab 87(10):4522\u20134527","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"4778_CR2","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/S0022-5347(05)67915-3","volume":"163","author":"PC Albertsen","year":"2000","unstructured":"Albertsen PC, Walters S, Hanley JA (2000) A comparison of cause of death determination in men previously diagnosed with prostate cancer who died in 1985 or 1995. J Urol 163(2):519\u2013523","journal-title":"J Urol"},{"key":"4778_CR3","unstructured":"Bipartisan Policy Center. Expanding access to obesity treatments for older adults. February 2022. Washington, D.C. 20005. https:\/\/bipartisanpolicy.org\/download\/?file=\/wp-content\/uploads\/2022\/02\/BPC_ExpandingAccessToObesityFinal.pdf. Accessed 16 Sept 2022"},{"issue":"5","key":"4778_CR4","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1111\/bju.13417","volume":"118","author":"P Boyle","year":"2016","unstructured":"Boyle P, Koechlin A, Bota M et al (2016) Endogenous and exogenous testosterone and the risk of prostate cancer and increased prostate-specific antigen (PSA) level: a meta-analysis. BJU Int 118(5):731\u2013741","journal-title":"BJU Int"},{"issue":"7","key":"4778_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100409","volume":"9","author":"JS Brand","year":"2014","unstructured":"Brand JS, Rovers MM, Yeap BB et al (2014) Testosterone, sex hormone-binding globulin and the metabolic syndrome in men: an individual participant data meta-analysis of observational studies. PLoS\u00a0One 9(7):e100409","journal-title":"PLoS\u00a0One"},{"issue":"18","key":"4778_CR6","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1200\/JCO.2014.59.1602","volume":"33","author":"LA Brinton","year":"2015","unstructured":"Brinton LA, Key TJ, Kolonel LN et al (2015) Prediagnostic sex steroid hormones in relation to male breast cancer risk. J Clin Oncol 33(18):2041\u20132050","journal-title":"J Clin Oncol"},{"issue":"5","key":"4778_CR7","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"},{"issue":"3","key":"4778_CR8","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.clgc.2018.01.005","volume":"16","author":"M Claps","year":"2018","unstructured":"Claps M, Petrelli F, Caffo O et al (2018) Testosterone levels and prostate cancer prognosis: systematic review and meta-analysis. Clin Genitourin Cancer 16(3):165-175.e2","journal-title":"Clin Genitourin Cancer"},{"key":"4778_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0480-2","author":"G Corona","year":"2016","unstructured":"Corona G, Giagulli VA, Maseroli E et al (2016) Testosterone supplementation and body composition: results from a meta-analysis of observational studies. J Endocrinol Invest. https:\/\/doi.org\/10.1007\/s40618-016-0480-2","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"4778_CR10","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/pcan.2013.60","volume":"17","author":"Y Cui","year":"2014","unstructured":"Cui Y, Zong H, Yan H, Zhang Y (2014) The effect of testosterone replacement therapy on prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 17(2):132\u2013143","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"12","key":"4778_CR11","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1038\/s42255-019-0146-4","volume":"1","author":"EA Day","year":"2019","unstructured":"Day EA, Ford RJ, Smith BK et al (2019) Metformin-induced increases in GDF15 are important for suppressing appetite and promoting weight loss. Nat Metab 1(12):1202\u20131208","journal-title":"Nat Metab"},{"issue":"3","key":"4778_CR12","doi-asserted-by":"crossref","first-page":"e13170","DOI":"10.1111\/obr.13170","volume":"22","author":"ML de Andrade","year":"2021","unstructured":"de Andrade ML, Fagundes Piccoli G, Richter da Natividade G, Frison Spiazzi B, Colpani V, Gerchman F (2021) Is lorcaserin really associated with increased risk of cancer? A systematic review and meta-analysis. Obes Rev 22(3):e13170","journal-title":"Obes Rev"},{"issue":"1","key":"4778_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1365-2265.2006.02560.x","volume":"65","author":"CA Derby","year":"2006","unstructured":"Derby CA, Zilber S, Brambilla D, Morales KH, McKinlay JB (2006) Body mass index, waist circumference and waist to hip ratio and change in sex steroid hormones: the massachusetts male ageing study. Clin Endocrinol (oxf) 65(1):125\u2013131","journal-title":"Clin Endocrinol (oxf)"},{"issue":"3","key":"4778_CR14","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.ecl.2011.05.007","volume":"40","author":"C Dimitrakakis","year":"2011","unstructured":"Dimitrakakis C (2011) Androgens and breast cancer in men and women. Endocrinol Metab Clin North Am 40(3):533\u2013547 (viii)","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"6","key":"4778_CR15","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","volume":"17","author":"SB Edge","year":"2010","unstructured":"Edge SB, Compton CC (2010) The american joint committee on cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471\u20131474","journal-title":"Ann Surg Oncol"},{"key":"4778_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173102","volume":"878","author":"S Eftekhari","year":"2020","unstructured":"Eftekhari S, Montazeri H, Tarighi P (2020) Synergistic anti-tumor effects of liraglutide, a glucagon-like peptide-1 receptor agonist, along with docetaxel on LNCaP prostate cancer cell line. Eur J Pharmacol 878:173102","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"4778_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1001\/jamaoncol.2017.2752","volume":"4","author":"L Emilsson","year":"2018","unstructured":"Emilsson L, Garcia-Albeniz X, Logan RW, Caniglia EC, Kalager M, Hernan MA (2018) Examining bias in studies of statin treatment and survival in patients with cancer. JAMA Oncol 4(1):63\u201370","journal-title":"JAMA Oncol"},{"issue":"1","key":"4778_CR18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12916-020-01895-1","volume":"19","author":"D Hang","year":"2021","unstructured":"Hang D, He X, Kvaerner AS et al (2021) Plasma sex hormones and risk of conventional and serrated precursors of colorectal cancer in postmenopausal women. BMC Med 19(1):18. https:\/\/doi.org\/10.1186\/s12916-020-01895-1","journal-title":"BMC Med"},{"issue":"4","key":"4778_CR19","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1158\/1055-9965.EPI-21-0996","volume":"31","author":"J Harbs","year":"2022","unstructured":"Harbs J, RinaldiS Gicquiau A, Keski-Rahkonen P, Mori N, Liu X, Kaaks R, Katzke V, Schulze MB, Agnoli C, Tumino R, Bueno-de-Mesquita B, Crous-Bou M, S\u00e1nchez MJ, Aizpurua A, Chirlaque MD, Gurrea AB, Travis RC, Watts EL, ChristakoudiS Tsilidis KK, Weiderpass E, Gunter MJ, Van Guelpen B, Murphy N, Harlid S (2022) Circulating sex hormone levels and colon cancer risk in men: a nested case-control study and meta-analysis. Cancer Epidemiol Biomarkers Prev 31(4):793\u2013803. https:\/\/doi.org\/10.1158\/1055-9965.EPI-21-0996","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"4778_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/aje\/155.2.176","volume":"155","author":"MA Hernan","year":"2002","unstructured":"Hernan MA, Hernandez-Diaz S, Werler MM, Mitchell AA (2002) Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 155(2):176\u2013184","journal-title":"Am J Epidemiol"},{"key":"4778_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f5039","volume":"347","author":"JL Hong","year":"2013","unstructured":"Hong JL, Meier CR, Sandler RS, Jick SS, Sturmer T (2013) Risk of colorectal cancer after initiation of orlistat: matched cohort study. BMJ 347:f5039","journal-title":"BMJ"},{"key":"4778_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-015-0380-x","author":"MP Humphries","year":"2015","unstructured":"Humphries MP, Jordan VC, Speirs V (2015) Obesity and male breast cancer: provocative parallels? BMC Med. https:\/\/doi.org\/10.1186\/s12916-015-0380-x","journal-title":"BMC Med"},{"issue":"7","key":"4778_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1111\/obr.12282","volume":"16","author":"DM Kelly","year":"2015","unstructured":"Kelly DM, Jones TH (2015) Testosterone and obesity. Obes Rev 16(7):581\u2013606","journal-title":"Obes Rev"},{"issue":"12","key":"4778_CR24","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/s41575-019-0189-8","volume":"16","author":"N Keum","year":"2019","unstructured":"Keum N, Giovannucci E (2019) Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol 16(12):713\u2013732","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"22","key":"4778_CR25","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1001\/jama.2016.7602","volume":"315","author":"R Khera","year":"2016","unstructured":"Khera R, Murad MH, Chandar AK et al (2016) Association of pharmacological treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA 315(22):2424\u20132434","journal-title":"JAMA"},{"issue":"4","key":"4778_CR26","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.cgh.2012.11.012","volume":"11","author":"JH Lin","year":"2013","unstructured":"Lin JH, Zhang SM, Rexrode KM et al (2013) Association between sex hormones and colorectal cancer risk in men and women. Clin Gastroenterol Hepatol 11(4):419-424.e1","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"4778_CR27","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/osp4.66","volume":"2","author":"M MacMillan","year":"2016","unstructured":"MacMillan M, Cummins K, Fujioka K (2016) What weight loss treatment options do geriatric patients with overweight and obesity want to consider? Obes Sci Pract 2(4):477\u2013482","journal-title":"Obes Sci Pract"},{"key":"4778_CR28","doi-asserted-by":"publisher","DOI":"10.29392\/joghr.3.e2019045","author":"JH Malenfant","year":"2019","unstructured":"Malenfant JH, Batsis JA (2019) Obesity in the geriatric population\u2014a global health perspective. J Glob Health Rep. https:\/\/doi.org\/10.29392\/joghr.3.e2019045. (Epub 2019 Aug 1)","journal-title":"J Glob Health Rep"},{"key":"4778_CR29","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/789653","volume":"2012","author":"C Mammi","year":"2012","unstructured":"Mammi C, Calanchini M, Antelmi A et al (2012) Androgens and adipose tissue in males: a complex and reciprocal interplay. Int J Endocrinol 2012:789653","journal-title":"Int J Endocrinol"},{"key":"4778_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s11357-014-9742-0","author":"WK Neto","year":"2015","unstructured":"Neto WK, Gama EF, Rocha LY et al (2015) Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies. Age (dordr). https:\/\/doi.org\/10.1007\/s11357-014-9742-0","journal-title":"Age (dordr)"},{"issue":"5","key":"4778_CR31","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1158\/1940-6207.CAPR-10-0072","volume":"3","author":"EA Platz","year":"2010","unstructured":"Platz EA (2010) Is prostate cancer prevention with selenium all in the genes? Cancer Prev Res (phila) 3(5):576\u2013578","journal-title":"Cancer Prev Res (phila)"},{"issue":"8","key":"4778_CR32","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s10552-011-9790-z","volume":"22","author":"S Rohrmann","year":"2011","unstructured":"Rohrmann S, Shiels MS, Lopez DS et al (2011) Body fatness and sex steroid hormone concentrations in US men: results from NHANES III. Cancer Causes Control 22(8):1141\u20131151","journal-title":"Cancer Causes Control"},{"issue":"1","key":"4778_CR33","first-page":"27","volume":"121","author":"C Seifarth","year":"2013","unstructured":"Seifarth C, Schehler B, Schneider HJ (2013) Effectiveness of metformin on weight loss in non-diabetic individuals with obesity. Exp Clin Endocrinol Diabetes 121(1):27\u201331","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"11","key":"4778_CR34","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1056\/NEJMp2003873","volume":"383","author":"J Sharretts","year":"2020","unstructured":"Sharretts J, Galescu O, Gomatam S, Andraca-Carrera E, Hampp C, Yanoff L (2020) Cancer risk associated with lorcaserin\u2014the FDA\u2019s review of the CAMELLIA-TIMI 61 trial. N Engl J Med 383(11):1000\u20131002","journal-title":"N Engl J Med"},{"issue":"2","key":"4778_CR35","doi-asserted-by":"publisher","first-page":"208","DOI":"10.5534\/wjmh.200010","volume":"39","author":"YJ Tak","year":"2021","unstructured":"Tak YJ, Lee SY (2021a) Anti-obesity drugs: long-term efficacy and safety: an updated review. World J Mens Health 39(2):208\u2013221","journal-title":"World J Mens Health"},{"issue":"1","key":"4778_CR36","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s13679-020-00422-w","volume":"10","author":"YJ Tak","year":"2021","unstructured":"Tak YJ, Lee SY (2021b) Long-term efficacy and safety of anti-obesity treatment: where do we stand? Curr Obes Rep 10(1):14\u201330","journal-title":"Curr Obes Rep"},{"key":"4778_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3294-8","volume-title":"Modeling survival data: extending the cox model","author":"TMGP Therneau","year":"2000","unstructured":"Therneau TMGP (2000) Modeling survival data: extending the cox model. Springer-Verlag, New York"},{"issue":"2","key":"4778_CR38","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1210\/jc.2006-1859","volume":"92","author":"TG Travison","year":"2007","unstructured":"Travison TG, Araujo AB, Kupelian V, O\u2019Donnell AB, McKinlay JB (2007) The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. J Clin Endocrinol Metab 92(2):549\u2013555","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"4778_CR39","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.2337\/dc14-0584","volume":"37","author":"KK Tsilidis","year":"2014","unstructured":"Tsilidis KK, Capothanassi D, Allen NE et al (2014) Metformin does not affect cancer risk: a cohort study in the U.K. clinical practice research datalink analyzed like an intention-to-treat trial. Diabetes Care 37(9):2522\u20132532","journal-title":"Diabetes Care"},{"key":"4778_CR40","doi-asserted-by":"publisher","unstructured":"Tyan YS, Lee YP, Chuang HY, Wang WH, Hwang JJ (2021) Effects of orlistat combined with enzalutamide and castration through inhibition of fatty acid synthase in a PC3 tumor-bearing mouse model. Biosci Rep. https:\/\/doi.org\/10.1042\/BSR20204203","DOI":"10.1042\/BSR20204203"},{"key":"4778_CR41","unstructured":"US Food and Drug Administration. FDA request the withdrawal of the weight-loss drug belviq, belviq (XR) (lorcaserin) from the mariket. 2020.\u00a0https:\/\/Www.fda.gov\/drugs\/drug-safety-and-availability\/fda-requests-withdrawal-weight-loss-drug-belviq-belviq-xr-lorcaserin-market. Accessed 27 Oct 2022"},{"issue":"6","key":"4778_CR42","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1097\/EDE.0b013e3181ba333c","volume":"20","author":"TJ VanderWeele","year":"2009","unstructured":"VanderWeele TJ (2009) On the distinction between interaction and effect modification. Epidemiology 20(6):863\u2013871","journal-title":"Epidemiology"},{"key":"4778_CR43","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0000000000001254","author":"Q Wang","year":"2021","unstructured":"Wang Q, Shi M (2021) Effect of metformin use on the risk and prognosis of colorectal cancer in diabetes mellitus: a meta-analysis. Anticancer Drugs. https:\/\/doi.org\/10.1097\/CAD.0000000000001254","journal-title":"Anticancer Drugs"},{"key":"4778_CR44","doi-asserted-by":"publisher","first-page":"8884450","DOI":"10.1155\/2020\/8884450","volume":"2020","author":"D Wang","year":"2020","unstructured":"Wang D, Li M, Li J et al (2020) Comprehensive characterization of androgen-responsive lncRNAs mediated regulatory network in hormone-related cancers. Dis Markers 2020:8884450","journal-title":"Dis Markers"},{"issue":"8 Suppl","key":"4778_CR45","first-page":"IV-3","volume":"40","author":"JL Warren","year":"2002","unstructured":"Warren JL, Klabunde CN, Schrag D, Bach PB, Riley GF (2002) Overview of the SEER-medicare data: content, research applications, and generalizability to the united states elderly population. Med Care 40(8 Suppl):IV-3\u201318","journal-title":"Med Care"},{"issue":"3","key":"4778_CR46","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/aja.2011.142","volume":"14","author":"KM Wilson","year":"2012","unstructured":"Wilson KM, Giovannucci EL, Mucci LA (2012) Lifestyle and dietary factors in the prevention of lethal prostate cancer. Asian J Androl 14(3):365\u2013374","journal-title":"Asian J Androl"},{"issue":"11","key":"4778_CR47","doi-asserted-by":"publisher","first-page":"3834","DOI":"10.1002\/jcb.26033","volume":"118","author":"C Wright","year":"2017","unstructured":"Wright C, Iyer AKV, Kaushik V, Azad N (2017) Anti-tumorigenic potential of a novel orlistat-AICAR combination in prostate cancer cells. J Cell Biochem 118(11):3834\u20133845","journal-title":"J Cell Biochem"},{"key":"4778_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32844","author":"W Yang","year":"2019","unstructured":"Yang W, Giovannucci EL, Hankinson SE et al (2019) Endogenous sex hormones and colorectal cancer survival among men and women. Int J Cancer. https:\/\/doi.org\/10.1002\/ijc.32844","journal-title":"Int J Cancer"},{"issue":"11","key":"4778_CR49","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1002\/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#","volume":"76","author":"C Zippin","year":"1995","unstructured":"Zippin C, Lum D, Hankey BF (1995) Completeness of hospital cancer case reporting from the SEER program of the national cancer institute. Cancer 76(11):2343\u20132350","journal-title":"Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04778-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-04778-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-04778-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,10]],"date-time":"2023-12-10T19:44:50Z","timestamp":1702237490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-04778-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,17]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["4778"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-04778-z","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,17]]},"assertion":[{"value":"16 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential conflicts of interest. This study used the linked SEER-Medicare database. The interpretation and reporting of these data are the sole responsibility of the authors. The authors acknowledge the efforts of the National Cancer Institute; the Office of Research, Development and Information, CMS; Information Management Services (IMS), Inc.; and the Surveillance, Epidemiology, and End Results (SEER) Program tumor registries in the creation of the SEER-Medicare database.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The secondary data analysis was approved by Institutional Review Board at the UTMB, Galveston, TX.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}